Phase
Condition
Menopause
Treatment
Shatavari + Ashwagandha extract
Placebo
Shatavari extract
Clinical Study ID
Ages 45-55 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Menopausal women aged 45 to 65 years with intact uterus and ovaries.
Participants who complained of irregular menstrual cycle in the past 12 months, witha forward or postpone of a cycle more 7 days. At least 2 cycles were missing duringthe past 12 months, or reported menopause for at least 60 days
Females with complaints of menopausal symptoms, e.g., hot flash, insomnia, migraine,easy irritation, etc.
Body mass index 18-35 kg/m2
Subject who has given written informed consent to participate in the study andunderstand the nature of the study
Able to read and write in English or any other vernacular language
No plan to commence new treatments over the study period.
Must have the ability and willingness to sign an informed consent and to comply withall study procedures.
Exclusion
Exclusion Criteria:
Participants taking any form of herbal extract in the last 3 months before studyentry.
Participants who are on hormone replacement therapy (HRT) for more than 3 months.
Participants with Present active medical, surgical, and gynaecological problems.
Participants with a history of alcohol, tobacco dependence, or any substance abuse
Participants who had undergone bilateral ovariectomy
Participants with history of breast or cervical carcinoma
Participants who taking medication that affect bone metabolism, includingglucocorticoid, anticonvulsant, and methotrexate.
Participants with Clinically relevant cardiovascular, gastrointestinal, hepatic,neurologic, endocrine, haematologic or other major systemic diseases makingimplementation of the protocol or other interpretation of the study result difficult
Participants with mental condition rendering the subject unable to understand thenature, scope, and possible consequences of the study
Participants with evidence of uncooperative attitude, including poor compliance.
Participants with inability to attend follow-up visit
Participants with any other medical condition (for example uncontrolled infection)that may, in the opinion of the Investigator, interfere with the study objective.
Patients with known hypersensitivity to Ashwagandha.
Patients who had participated in other clinical trials during the previous 3 months.
Patients who have any clinical condition, according to the investigator who does notallow safe fulfilment of clinical trial protocol
Study Design
Study Description
Connect with a study center
SF Research Institute, Inc.
San Francisco, California 94127
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.